The DOI matches its Crossref record.
Liver transplantation for sclerosing cholangitis
Open accessAbstract
The clinical course of 37 patients who underwent 46 liver transplantations for primary (n = 33) and secondary (n = 4) sclerosing cholangitis was reviewed. The median follow-up was 37 months. The patient and graft survivals for patients with primary sclerosing cholangitis at 1, 2, and 5 years were 96.9%, 91.6%, 87.9%, and 83.1%, 74.2%, 65.2%, respectively. In the patients with primary sclerosing cholangitis (PSC), prior surgery except for simple cholecystectomy was associated with significantly greater operative time and blood loss. No cholangiocarcinoma was identified at the time of transplantation. Human leukocyte antigen typing for PSC patients was heavily weighed toward B8 (58.8%) compared with control (11.8%). Sixty-two percent of patients with PSC also had inflammatory bowel disease. Moderate or severe rejection requiring OKT3, “rescue therapy” with FK506, or retransplantation was relatively higher in patients with inflammatory bowel disease (70%) versus patients without inflammatory bowel disease (36.4%) and a matched control group (37.5%). Progressive inflammatory bowel disease was seen in 6 of 19 patients, with 3 developing cancer and a dysplasia. Two patients in the entire group died of sepsis and 3 of colon cancer (2 recurrent and 1 primary). These data demonstrate that excellent survival results can be achieved in this group of patients. Rejection is frequent and often severe and steroid refractory. Colon cancer represents the most frequent cause of death in PSC patients after liver transplantation and demands constant attention. (Hepatology 1995;22:451-457.)
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
AASLD practice guidelines: Evaluation of the patient for liver transplantation†
Murray, K. F., & Carithers, R. L. (2005) · Hepatology · doi:10.1002/hep.20704 · Cited by 939
Soetikno, R. M., Lin, O. S., Heidenreich, P. A., Young, H. S., & Blackstone, M. O. (2002) · Gastrointestinal Endoscopy · doi:10.1067/mge.2002.125367 · Cited by 623
Primary sclerosing cholangitis
Hirschfield, G. M., Karlsen, T. H., Lindor, K. D., & Adams, D. H. (2013) · The Lancet · doi:10.1016/s0140-6736(13)60096-3 · Cited by 592
Recurrence of Primary Sclerosing Cholangitis Following Liver Transplantation
Graziadei, I. W., Wiesner, R. H., Batts, K. P., Marotta, P. J., LaRusso, N. F., Porayko, M. K., Hay, E. J., Gores, G. J., Charlton, M. R., Ludwig, J., et al. (1999) · Hepatology · doi:10.1002/hep.510290427 · Cited by 375
Liver biopsy interpretation for causes of late liver allograft dysfunction
(2006) · Hepatology · doi:10.1002/hep.21280 · Cited by 359
Long-term results of patients undergoing liver transplantation for primary sclerosing cholangitis
Graziadei, I. W., Wiesner, R. H., Marotta, P. J., Porayko, M. K., Hay, E. J., Charlton, M. R., Poterucha, J. J., Rosen, C. B., Gores, G. J., LaRusso, N. F., et al. (1999) · Hepatology · doi:10.1002/hep.510300501 · Cited by 359
Goss, J. A., Shackleton, C. R., Farmer, D. G., Arnaout, W. S., Seu, P., Markowitz, J. S., Martin, P., Stribling, R. J., Goldstein, L. I., & Busuttil, R. W. (1997) · Annals of Surgery · doi:10.1097/00000658-199705000-00004 · Cited by 328
Increased cancer risk after liver transplantation: a population-based study
Haagsma, E. B., Hagens, V. E., Schaapveld, M., van den Berg, A. P., de Vries, E. G. E., Klompmaker, I. J., Slooff, M. J. H., & Jansen, P. L. M. (2001) · Journal of Hepatology · doi:10.1016/s0168-8278(00)00077-5 · Cited by 323
Recurrence of autoimmune liver disease after liver transplantation: A systematic review
Gautam, M., Cheruvattath, R., & Balan, V. (2006) · Liver Transplantation · doi:10.1002/lt.20910 · Cited by 274
Autoimmune liver disease, autoimmunity and liver transplantation
Carbone, M., & Neuberger, J. M. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2013.09.020 · Cited by 250
Recurrence and rejection in liver transplantation for primary sclerosing cholangitis
Fosby, B. (2012) · World Journal of Gastroenterology · doi:10.3748/wjg.v18.i1.1 · Cited by 175
Brandsæter, B., Broomé, U., Isoniemi, H., Friman, S., Hansen, B., Schrumpf, E., Oksanen, A., Ericzon, B.-G., Höckerstedt, K., Mäkisalo, H., et al. (2003) · Liver Transplantation · doi:10.1053/jlts.2003.50169 · Cited by 71
“6 (1-34) Creatinine in mol/L, mean/median (range) 82/75 (30-497) 80/74 (30-262) 85/76 (41-497) Creatinine 150 mol/L (%) 9 (4) 4 (3) 5 (4) Bilirubin in mol/L, mean/median (range) 176/121 (6-787) 199/143 (9-620) 157/103 (6-787)‡ Bilirubin 150 mol/L (%) 112 (44) 54 (47) 58 (42) Albumin in g/L, mean/median (range) 28/28 (…”
Nakanuma, Y., Zen, Y., & Portmann, B. C. (2012) · MacSween's Pathology of the Liver · doi:10.1016/b978-0-7020-3398-8.00010-6 · Cited by 56
Peverelle, M., Paleri, S., Hughes, J., De Cruz, P., & Gow, P. J. (2020) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izz325 · Cited by 47
Metadata
- Authors
- Narumi, S., Roberts, J. P., Emond, J. C., Lake, J., & Ascher, N. L.
- Venue
- Hepatology
- Published
- 1995-08
- Volume
- 22
- Issue
- 2
- Pages
- 451-457
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W2060227921
- Cited by
- 195
- References
- 0
- FWCI
- 7.23
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.